Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Other Accumulated Expenses (2022 - 2024)

Immuneering has reported Other Accumulated Expenses over the past 3 years, most recently at $59657.0 for Q3 2024.

  • Quarterly results put Other Accumulated Expenses at $59657.0 for Q3 2024, down 25.89% from a year ago — trailing twelve months through Sep 2024 was $59657.0 (down 25.89% YoY), and the annual figure for FY2023 was $259770.0, up 1212.23%.
  • Other Accumulated Expenses for Q3 2024 was $59657.0 at Immuneering, down from $90242.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for IMRX hit a ceiling of $259770.0 in Q4 2023 and a floor of $19796.0 in Q4 2022.
  • Median Other Accumulated Expenses over the past 3 years was $47213.0 (2022), compared with a mean of $65931.8.
  • Peak annual rise in Other Accumulated Expenses hit 1212.23% in 2023, while the deepest fall reached 44.23% in 2023.
  • Immuneering's Other Accumulated Expenses stood at $19796.0 in 2022, then skyrocketed by 1212.23% to $259770.0 in 2023, then crashed by 77.03% to $59657.0 in 2024.
  • The last three reported values for Other Accumulated Expenses were $59657.0 (Q3 2024), $90242.0 (Q2 2024), and $23634.0 (Q1 2024) per Business Quant data.